Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31468 | 122 | 37.4 | 80% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
600 | 13345 | LAMININ//FIBRONECTIN//INVASION & METASTASIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARBOXYAMIDOTRIAZOLE | Author keyword | 14 | 100% | 6% | 7 |
2 | CARBOXYAMIDO TRIAZOLE | Author keyword | 9 | 83% | 4% | 5 |
3 | PROOFREADING STIMULATION | Author keyword | 3 | 100% | 2% | 3 |
4 | EQUIMOLAR COMBINATIONS OF NUCLEOTIDES PRECURSORS | Author keyword | 1 | 100% | 2% | 2 |
5 | NEW ADJUVANT CANCER THERAPY | Author keyword | 1 | 100% | 2% | 2 |
6 | MICROPIPETTE TECHNIQUE | Author keyword | 1 | 40% | 2% | 2 |
7 | SIGNAL TRANSDUCTION THERAPY | Author keyword | 1 | 25% | 2% | 3 |
8 | CHOROIDAL ENDOTHELIAL CELL | Author keyword | 1 | 33% | 2% | 2 |
9 | 4 HYDROXYISOPHTHALIC ACID | Author keyword | 1 | 50% | 1% | 1 |
10 | ANTITUMOR ALKYLATING AGENTS | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CALCIUM INFLUX INHIBITOR | 21 | 85% | 9% | 11 |
2 | L651582 | 21 | 85% | 9% | 11 |
3 | CARBOXYAMIDO TRIAZOLE | 6 | 48% | 8% | 10 |
4 | PSEUDOPOD PROTRUSION | 4 | 75% | 2% | 3 |
5 | L 651 582 | 3 | 100% | 2% | 3 |
6 | SIGNAL TRANSDUCTION INHIBITOR | 3 | 33% | 7% | 8 |
7 | MICRONIZED FORMULATION | 2 | 36% | 3% | 4 |
8 | INFLUX INHIBITOR | 1 | 50% | 2% | 2 |
9 | CA2 POOL | 1 | 50% | 1% | 1 |
10 | CNS CONSORTIUM | 1 | 50% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Calcium as a molecular target in angiogenesis | 2003 | 41 | 74 | 18% |
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy | 2004 | 3 | 111 | 20% |
CALCIUM-MEDIATED SIGNAL-TRANSDUCTION - BIOLOGY, BIOCHEMISTRY, AND THERAPY | 1994 | 71 | 76 | 9% |
Antiangiogenesis therapeutic strategies in prostate cancer | 2002 | 7 | 130 | 15% |
Angiogenesis inhibition: Drugs in clinical trials | 1999 | 4 | 47 | 13% |
Signal transduction as a therapeutic target | 1996 | 9 | 97 | 9% |
The relationship between adhesion, migration of cancer cells and metastasis. | 1998 | 3 | 19 | 5% |
Cancer Invasion and Metastasis: Discovering New Targets For Diagnosis and Therapeutics | 2009 | 0 | 83 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SCI BOARD | 1 | 14% | 3.3% | 4 |
2 | SERV HEMATOL CLIN BIOL | 0 | 25% | 0.8% | 1 |
3 | SEZIONE BIOL GENET | 0 | 13% | 0.8% | 1 |
4 | BECKMAN MACULA OPHTHALMOL | 0 | 100% | 0.8% | 1 |
5 | DEPISTAGE HEMOCHROMATOSE | 0 | 100% | 0.8% | 1 |
6 | MED OVARIAN CANC CLIN | 0 | 100% | 0.8% | 1 |
7 | PHYSIOL ACTIV HUMAINE | 0 | 100% | 0.8% | 1 |
8 | PRIMARY CARE STAT | 0 | 100% | 0.8% | 1 |
9 | REHAB RD COE | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000152470 | SERV 151Z2//PP 2A//STRITCH MED OTOLARYNGOL |
2 | 0.0000135824 | NEUTROPHIL SIGNALLING GRP//MOL SIGNALLING GRP//FFP 18 |
3 | 0.0000115576 | ALKALINE TIDE//HUMAN OSCC//IN VIVO ENVIRONMENT |
4 | 0.0000094193 | STIM1//ORAI1//ORAI |
5 | 0.0000086139 | CFU GM ASSAY//ACUTE NEUTROPENIA//PYRAZINE DIAZOHYDROXIDE |
6 | 0.0000078942 | TNP 470//METHIONINE AMINOPEPTIDASE//AGM 1470 |
7 | 0.0000059783 | CATCH BONDS//BELL MODEL//CELL ROLLING |
8 | 0.0000056199 | AUTOCRINE MOTILITY FACTOR//AUTOCRINE MOTILITY FACTOR RECEPTOR//PHOSPHOGLUCOSE ISOMERASE |
9 | 0.0000049632 | SURAMIN//HT 29 D4 CELLS//SURAMIN ANALOGUES |
10 | 0.0000048577 | PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE//PHOSPHORIBOSYL PYROPHOSPHATE SYNTHETASE//ARTHROBACTER A302 |